Poly (ADP-ribose) polymerase

PARP is a promising new therapy for thoracic cancers like mesothelioma. PARP is short for Poly (ADP-ribose) polymerase. PARP is involved in repairing damaged DNA in cells. PARP can work against the effects of chemotherapy by repairing damaged tumor cells. This action allows the tumors to keep growing. If doctors can block PARP in patients with thoracic cancer, they might be able to stop the growth of tumors. A New Hope for Mesothelioma Patients Mesothelioma is a type of cancer that affects the thin layer of tissue that covers the organs in the chest, abdomen, and other areas. The most common cause of mesothelioma is exposure to asbestos. When asbestos fibers are inhaled or swallowed, they can cause inflammation that…